{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:52:50Z","timestamp":1769097170812,"version":"3.49.0"},"reference-count":32,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2019,10,15]]},"abstract":"<jats:p>Introduction: Failure to obtain complete blood clotting in serum is a common laboratory problem. Our aim was to determine whether snake prothrombin activators are effective in clotting blood and producing quality serum for analyte measurement in anticoagulated patients. Materials and methods: Whole blood clotting was studied in a total of 64 blood samples (41 controls, 20 Warfarin patients, 3 anticoagulated patients using snake venom prothrombin activator (OsPA)) with plain tubes. Coagulation was analysed using a visual assay, Hyland-Clotek and thromboelastography. Healthy control blood was spiked with a range of anticoagulants to determine the effectiveness of OsPa-induced clotting. A paired analysis of a Dabigatran patient and a control investigated the effectiveness of the OsPA clotting tubes. Biochemical analytes (N = 31) were determined for 7 samples on chemistry and immunoassay analysers and compared with commercial tubes. Results: Snake venom prothrombin activators efficiently coagulated blood and plasma spiked with heparin and commonly used anticoagulants. Clotting was observed in the presence of anticoagulants whereas no clotting was observed in BDRST tubes containing 3 U\/mL of heparin. Snake venom prothrombin activator enhanced heparinised blood clotting by shortening substantially the clotting time and improving significantly the strength of the clot. Comparison of 31 analytes from the blood of five healthy and two anticoagulated participants gave very good agreement between the analyte concentrations determined. Conclusions: Our results showed that the snake venom prothrombin activators OsPA and PtPA efficiently coagulated recalcified and fresh bloods with or without added anticoagulants. These procoagulants produced high quality serum for accurate analyte measurement.<\/jats:p>","DOI":"10.11613\/bm.2019.030706","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T15:13:07Z","timestamp":1570633987000},"page":"542-558","source":"Crossref","is-referenced-by-count":5,"title":["Rapid serum tube technology overcomes problems associated with use of anticoagulants"],"prefix":"10.11613","volume":"29","author":[{"given":"Kong-Nan","family":"Zhao","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Queensland, Translational Research Institute, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"de Jersey","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin F","family":"Lavin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Queensland, Translational Research Institute, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P","family":"Masci","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Queensland, Translational Research Institute, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grant","sequence":"additional","affiliation":[{"name":"Q-Sera Pty Ltd, Level 9,31 Queen St, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambro A","family":"Johnson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Queensland, Translational Research Institute, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goce","family":"Dimeski","sequence":"additional","affiliation":[{"name":"Chemical Pathology, Princess Alexandra Hospital, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4885","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"key20191010064335_r1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00001721-200006000-00011","article-title":"Textilinins from Pseudonaja textilis textilis. Characterization of two plasmin inhibitors that reduce bleeding in an animal model.","volume":"11","author":"Masci","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key20191010064335_r2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","article-title":"Activation of factor XI by products of prothrombin activation.","volume":"118","author":"Matafonov","year":"2011","journal-title":"Blood"},{"key":"key20191010064335_r3","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/toxins2061554","article-title":"Procoagulant adaptation of a blood coagulation prothrombinase-like enzyme complex in australian elapid venom.","volume":"2","author":"Bos","year":"2010","journal-title":"Toxins (Basel)"},{"key":"key20191010064335_r4","first-page":"19","article-title":"Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.","volume":"2","author":"Bos","year":"2010","journal-title":"J Coagul Disord"},{"key":"key20191010064335_r5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/cclm-2018-0397","article-title":"Next-generation rapid serum tube technology using prothrombin activator coagulant: fast, high-quality serum from normal samples.","volume":"57","author":"Zhao","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"key20191010064335_r6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/CCLM.2010.141","article-title":"Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?","volume":"48","author":"Dimeski","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"key20191010064335_r7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinchem\/44.3.606","article-title":"Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration.","volume":"44","author":"Ramamurthy","year":"1998","journal-title":"Clin Chem"},{"key":"key20191010064335_r8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1981.tb29778.x","article-title":"The interaction of protein-bound heparin and antithrombin III.","volume":"370","author":"Shanberge","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"key20191010064335_r9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/clinchem\/26.1.173","article-title":"Evaluation of a thrombin-containing blood-collection tube.","volume":"26","author":"Steindel","year":"1980","journal-title":"Clin Chem"},{"key":"key20191010064335_r10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/769479","article-title":"Thrombin-accelerated quick clotting serum tubes: an evaluation with 22 common biochemical analytes.","volume":"2013","author":"Ng","year":"2013","journal-title":"Adv Hematol"},{"key":"key20191010064335_r11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/cclm-2016-0806","article-title":"Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube.","volume":"55","author":"Dimeski","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"key20191010064335_r12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","article-title":"Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.","volume":"41","author":"Smythe","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"key20191010064335_r13","first-page":"825","article-title":"Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis.","volume":"17","author":"Masci","year":"1988","journal-title":"Biochem Int"},{"key":"key20191010064335_r14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijfoodmicro.2012.02.003","article-title":"Biodiversity of antifungal lactic acid bacteria isolated from raw milk samples from cow, ewe and goat over one-year period.","volume":"155","author":"Delavenne","year":"2012","journal-title":"Int J Food Microbiol"},{"key":"key20191010064335_r15","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00228-012-1263-0","article-title":"Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery.","volume":"68","author":"Delavenne","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"key20191010064335_r16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007976","article-title":"The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method.","volume":"96","author":"Hernaningsih","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key20191010064335_r17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1258\/acb.2007.007183","article-title":"Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation.","volume":"45","author":"Tanner","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"key20191010064335_r18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1258\/acb.2010.010230","article-title":"Centrifugation protocols: tests to determine optimal lithium heparin and citrate plasma sample quality.","volume":"48","author":"Dimeski","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"key20191010064335_r19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/cclm-2016-0806","article-title":"Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube.","volume":"55","author":"Dimeski","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"key20191010064335_r20","doi-asserted-by":"crossref","first-page":"25895","DOI":"10.1074\/jbc.M113.485268","article-title":"Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.","volume":"288","author":"Viskov","year":"2013","journal-title":"J Biol Chem"},{"key":"key20191010064335_r21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/026765910101600209","article-title":"Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.","volume":"16","author":"Wallock","year":"2001","journal-title":"Perfusion"},{"key":"key20191010064335_r22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0041-0101(82)90014-9","article-title":"In vitro coagulant properties of venoms from Australian snakes.","volume":"20","author":"Chester","year":"1982","journal-title":"Toxicon"},{"key":"key20191010064335_r23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jth.12601","article-title":"\u03b3T -S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo.","volume":"12","author":"Sheffield","year":"2014","journal-title":"J Thromb Haemost"},{"key":"key20191010064335_r24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/jm0109513","article-title":"Structure-based design of novel potent nonpeptide thrombin inhibitors.","volume":"45","author":"Hauel","year":"2002","journal-title":"J Med Chem"},{"key":"key20191010064335_r25","unstructured":"Stuart C. Anticoagulants: The brave new world, Available at: http:\/\/www.cardiovascularbusiness.com\/topics\/electrophysiology-arrhythmia\/anticoagulants-brave-new-world. Accessed December 1st 2018."},{"key":"key20191010064335_r26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1373\/clinchem.2004.036533","article-title":"Comparison of serum and heparinized plasma samples for measurement of chemistry analytes.","volume":"50","author":"Miles","year":"2004","journal-title":"Clin Chem"},{"key":"key20191010064335_r27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1645054","article-title":"Development of a heat-treated factor VIII\/von Willebrand factor concentrate prepared from heparinized plasma.","volume":"63","author":"Palmer","year":"1990","journal-title":"Thromb Haemost"},{"key":"key20191010064335_r28","unstructured":"Dimeski G. 2010, PhD Thesis, University of Queensland, Australia"},{"key":"key20191010064335_r29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-12-9","article-title":"Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.","volume":"12","author":"O\u2019Neal","year":"2014","journal-title":"J Transl Med"},{"key":"key20191010064335_r30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000182098","article-title":"Autoimmune thyroiditis with transient thyrotoxicosis: comparison between painful thyroiditis and painless thyroiditis.","volume":"36","author":"Shigemasa","year":"1991","journal-title":"Horm Res"},{"key":"key20191010064335_r31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/clinchem\/21.3.424","article-title":"Lipase-triggered kinetic assay of serum triglycerides.","volume":"21","author":"Bucolo","year":"1975","journal-title":"Clin Chem"},{"key":"key20191010064335_r32","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2017.74.7642","article-title":"Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.","volume":"35","author":"B\u00fcttner","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/29\/3\/10.11613\/BM.2019.030706\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T11:25:30Z","timestamp":1611487530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/29\/3\/10.11613\/BM.2019.030706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,15]]},"published-print":{"date-parts":[[2019,10,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2019.030706","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}